Harry Jr Penner - Net Worth and Insider Trading
Harry Jr Penner Net Worth
The estimated net worth of Harry Jr Penner is at least $23,441 dollars as of 2024-11-10. Harry Jr Penner is the Director of Celldex Therapeutics Inc and owns about 894 shares of Celldex Therapeutics Inc (CLDX) stock worth over $23,441. Details can be seen in Harry Jr Penner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harry Jr Penner has not made any transactions after 2013-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Harry Jr Penner
Harry Jr Penner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harry Jr Penner owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .
Click here to see the complete history of Harry Jr Penner’s form 4 insider trades.
Insider Ownership Summary of Harry Jr Penner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2013-12-06 | director |
Harry Jr Penner Latest Holdings Summary
Harry Jr Penner currently owns a total of 1 stock. Harry Jr Penner owns 894 shares of Celldex Therapeutics Inc (CLDX) as of December 6, 2013, with a value of $23,441.
Latest Holdings of Harry Jr Penner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CLDX | Celldex Therapeutics Inc | 2013-12-06 | 894 | 26.22 | 23,441 |
Holding Weightings of Harry Jr Penner
Harry Jr Penner Form 4 Trading Tracker
According to the SEC Form 4 filings, Harry Jr Penner has made a total of 0 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years. The most-recent trade in Celldex Therapeutics Inc is the sale of 1,182 shares on December 6, 2013, which brought Harry Jr Penner around $434,336.
Insider Trading History of Harry Jr Penner
- 1
Harry Jr Penner Trading Performance
GuruFocus tracks the stock performance after each of Harry Jr Penner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harry Jr Penner is 22.22%. GuruFocus also compares Harry Jr Penner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harry Jr Penner within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Harry Jr Penner's insider trading performs compared to the benchmark.
Performance of Harry Jr Penner
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 28.95 | | | | | |
| Relative Return to S&P 500(%) | 23.43 | | | | | |
Harry Jr Penner Ownership Network
Ownership Network List of Harry Jr Penner
Ownership Network Relation of Harry Jr Penner
Harry Jr Penner Owned Company Details
What does Celldex Therapeutics Inc do?
Who are the key executives at Celldex Therapeutics Inc?
Harry Jr Penner is the director of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include SVP & Chief Product Dev Officer Elizabeth Crowley , SVP and CFO Samuel Bates Martin , and SVP & Chief Medical Officer Diane C. Young .
Celldex Therapeutics Inc (CLDX) Insider Trades Summary
Over the past 18 months, Harry Jr Penner made no insider transaction in Celldex Therapeutics Inc (CLDX). Other recent insider transactions involving Celldex Therapeutics Inc (CLDX) include a net sale of 83,597 shares made by Elizabeth Crowley , a net sale of 97,088 shares made by Margo Heath-chiozzi , and a net sale of 52,172 shares made by Samuel Bates Martin .
In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 353,560 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 353,560 shares.
Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Celldex Therapeutics Inc Insider Transactions
Harry Jr Penner Mailing Address
Above is the net worth, insider trading, and ownership report for Harry Jr Penner. You might contact Harry Jr Penner via mailing address: C/o Genaissance Pharmaceuticals, 5 Science Park, New Haven Ct 06511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
